Clinical Trial Update: Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of peginesatide injections for maintaining anemia in chronic kidney disease patients on hemodialysis or not on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Peginesatide (peginesatide)

Snippet

Sponsor: Takeda | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2012-07-27